Hardie Molly G. 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-16 4:25 pm Purchase |
2021-07-01 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
Hardie Molly G. | 3,451,152 8.500% |
3,451,152 (New Position) |
Filing |